[Infliximab in active ulcerative colitis -- proven efficacy as induction and maintenance treatment].
Heidemann
J
J
Medizinische Klinik und Poliklinik B, Universitätsklinikum Münster, Münster.
Kucharzik
T F
TF
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000517:prevention & control*; D019317:Evidence-Based Medicine; D006801:Humans; D000069285:Infliximab; D010818:Practice Patterns, Physicians'; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab